Document:

<PAGE>

                                   EXHIBIT 4.1

              STOCK PURCHASE AGREEMENT AND WARRANT AGREEMENT (FORM)

                                PRIVATE PLACEMENT

<PAGE>

                            STOCK PURCHASE AGREEMENT

         THIS STOCK PURCHASE AGREEMENT ("Agreement"), dated as of
________________, 1999, is by and between _____________________, an
individual ("PURCHASER"), and THEHEALTHCHANNEL.COM, INC., a Delaware
corporation ("SELLER") (collectively, the "PARTIES").

                               W I T N E S S E T H

         WHEREAS, SELLER is offering for sale a maximum of 5,000,000 units
(the "Units"), each unit consisting of one share of SELLER'S common stock
(the "Shares") and one warrant, exercisable at $0.75 and expiring two years
after the date of issuance (the "Warrants"), at $0.75 per Unit, minimum
investment $25,000 (33,333 Units).

         WHEREAS, SELLER desires to sell to PURCHASER and PURCHASER desires to
purchase from SELLER, __________ Units of SELLER (the "Units") upon the terms
and conditions set forth herein.

         NOW THEREFORE, in consideration of the promises and respective mutual
agreements herein contained, it is agreed by and between the PARTIES hereto as
follows:

                                    ARTICLE 1
                         SALE AND PURCHASE OF THE UNITS

         1.1      Sale of the Units.  Upon execution of this Agreement (the
"Closing"), subject to the terms and conditions herein set forth, and on the
basis of the representations, warranties and agreements herein contained,
SELLER shall sell to PURCHASER, and PURCHASER shall purchase from SELLER, the
Units.

         1.2      Instruments of Conveyance and Transfer.  As soon as
practicable after the Closing, SELLER shall deliver a certificate or
certificates representing the Units of SELLER to PURCHASER sufficient to
transfer all right, title and interest in the Units to PURCHASER.

         1.3      Consideration and Payment for the Units.  In consideration
for the Units, PURCHASER shall pay a purchase price of a total of
________________________________dollars ($_______) ($0.75 per Unit)
("Purchase Price").

                                    ARTICLE 2
              REPRESENTATIONS AND COVENANTS OF SELLER AND PURCHASER

         2.1      SELLER hereby represents and warrants that:

         (a)      The Units issued hereunder (the "Units") have been duly
authorized by the appropriate corporate action of SELLER.

         (b)      SELLER shall transfer title, in and to the Units to
PURCHASER free and clear of all liens, security interests, pledges,
encumbrances, charges, restrictions, demands and claims, of any kind and
nature whatsoever, whether direct or indirect or contingent.

         2.2      As soon as practicable after the Closing Date, SELLER shall
deliver to PURCHASER a certificate or certificates representing the Units
subject to no liens, security interests, pledges, encumbrances, charges,
restrictions, demands or claims in any other party whatsoever, except as set
forth in the legend on the certificate, which legend shall provide as follows:

         THE SHARES (OR OTHER SECURITIES) REPRESENTED BY THIS CERTIFICATE
         HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THE
         SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH
         REGISTRATION OR AN OPINION OF COUNSEL THAT AN EXEMPTION FROM
         REGISTRATION UNDER SUCH ACT IS AVAILABLE.

<PAGE>

         2.3.     PURCHASER acknowledges that the Units will initially be
"restricted securities" (as such term is defined in Rule 144 promulgated
under the Securities Act of 1933, as amended ("Rule 144"), that the Units
will include the foregoing restrictive legend, and, except as otherwise set
forth in this Agreement, that the Units cannot be sold for a period of at
least one year from the date of issuance unless registered with the United
States Securities and Exchange Commission ("SEC") and qualified by
appropriate state securities regulators, or unless PURCHASER obtains written
consent from SELLER and otherwise complies with an exemption from such
registration and qualification (including, without limitation, compliance
with Rule 144).

         2.4      SELLER certifies that attached hereto as Exhibit A is the
Warrant Agreement and form of Warrant Certificate setting forth the terms of
the Warrants. Exhibit A is incorporated herein by reference as though fully
set forth herein.

         2.5      PURCHASER acknowledges and agrees that SELLER makes no
other representations or warranties with respect to the Units or the SELLER.

         2.6      PURCHASER represents and warrants to SELLER as follows:

                  (a)      PURCHASER has adequate means of providing for
current needs and contingencies, has no need for liquidity in the investment,
and is able to bear the economic risk of an investment in the Units offered
by SELLER of the size contemplated. PURCHASER represents that PURCHASER is
able to bear the economic risk of the investment and at the present time
could afford a complete loss of such investment. PURCHASER has had a full
opportunity to inspect the books and records of the SELLER and to make any
and all inquiries of SELLER officers and directors regarding the SELLER and
its business as PURCHASER has deemed appropriate.

                  (b)      PURCHASER is an "Accredited Investor" as defined
in Regulation D of the Securities Act of 1933 (the "Act") and PURCHASER,
either alone or with PURCHASER's professional advisers who are unaffiliated
with, have no equity interest in and are not compensated by SELLER or any
affiliate or selling agent of SELLER, directly or indirectly, has sufficient
knowledge and experience in financial and business matters that PURCHASER is
capable of evaluating the merits and risks of an investment in the Units
offered by SELLER and of making an informed investment decision with respect
thereto and has the capacity to protect PURCHASER's own interests in
connection with PURCHASER's proposed investment in the Units.

                  (c)      PURCHASER is acquiring the Units solely for
PURCHASER'S own account as principal, for investment purposes only and not with
a view to the resale or distribution thereof, in whole or in part, and no other
person or entity has a direct or indirect beneficial interest in such Units.

                  (d)      PURCHASER will not sell or otherwise transfer the
Units without registration under the Act or an exemption therefrom and fully
understands and agrees that PURCHASER must bear the economic risk of
PURCHASER'S purchase for an indefinite period of time because, among other
reasons, the Units have not been registered under the Act or under the
securities laws of any state and, therefore, cannot be resold, pledged,
assigned or otherwise disposed of unless they are subsequently registered
under the Act and under the applicable securities laws of such states or
unless an exemption from such registration is available.

                                    ARTICLE 3
                               REGISTRATION RIGHTS

         3.1      Piggyback Registration Rights.  If the COMPANY at any time
proposes to register any of its securities under the Act, including under an
SB-2 Registration Statement or otherwise, the COMPANY will use its best
efforts to cause all of the Shares and all of the shares of common stock
underlying the Warrants owned by PURCHASER to be registered under the Act
(with the securities which the COMPANY at the time propose to register), all
to the extent requisite to permit the sale or other disposition by the
PURCHASER; provided, however, that the COMPANY may, as a condition precedent
to its effecting such registration, require the PURCHASER to agree with the
COMPANY and the managing underwriter or underwriters of the offering to be
made by the COMPANY in connection with such registration that the PURCHASER
will not sell any securities of the same class or convertible

<PAGE>

into the same class as those registered by the COMPANY (including any class
into which the securities registered by the COMPANY are convertible) for such
reasonable period after such registration becomes effective as shall then be
specified in writing by such underwriter or underwriters if in the opinion of
such underwriter or underwriters the COMPANY's offering would be materially
adversely affected in the absence of such an agreement. All expenses incurred
by the COMPANY in complying with this Section, including without limitation
all registration and filing fees, listing fees, printing expenses, fees and
disbursements of all independent accounts, or counsel for the COMPANY and or
counsel for the PURCHASER and the expense of any special audits incident to
or required by any such registration and the expenses of complying with the
securities or blue sky laws of any jurisdiction shall be paid by the COMPANY.
Notwithstanding the foregoing, PURCHASER shall pay all underwriting discounts
or commissions with respect to any securities sold by the PURCHASER.

         3.2      Indemnification.

                  (a)      In the event of any registration of any of its
securities under the Act pursuant to this Section, the COMPANY hereby
indemnifies and holds harmless the PURCHASER (which phrase shall include any
underwriters of such securities), their respective directors and officers,
and each other person who participates, in the offering of such securities
and each other person, if any, who controls the PURCHASER, or such
participating persons within the meaning of the Act, against any losses,
claims, damages or liabilities, joint or several, to which each the PURCHASER
or any such director or officer or participating person or controlling person
may become subject under the Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of
or are based upon any untrue statement or alleged untrue statement of any
material fact contained, on the effective date thereof, in any registration
statement under which such securities were registered under the Act, any
preliminary prospectus or final prospectus contained therein, or any
amendment or supplement thereto, or arise out of or are based upon any
omission or alleged omission to state therein an material fact required to be
stated therein or necessary to make the statements therein not misleading;
and will reimburse each the PURCHASER and each director, officer or
participating or controlling person for any legal or any other expenses
reasonably incurred by the PURCHASER or such director, officer or
participating or controlling person in connection with investigating or
defending any such loss, claim, damage, liability or action; provided,
however, that the COMPANY shall not be liable in any such case to the extent
that any such loss, claim, damage or liability arises out of is based upon an
untrue statement or alleged untrue statement or omission or alleged omission
made in such registration statement, preliminary prospectus or prospectus or
amendment or supplement in reliance upon and in conformity with written
information furnished to the COMPANY through an instrument duly executed by
the PURCHASER specifically stating that it is for use therein. Such indemnity
shall remain in full force and effect regardless of any investigation made by
or on behalf of the PURCHASER or such directors, officer or participating or
controlling person, and shall survive the transfer of such securities by the
PURCHASER.

                  (b)      The PURCHASER shall by acceptance thereof,
indemnify and hold harmless the COMPANY and its directors and officers, and
each person, if any who controls the COMPANY, against any losses, claims,
damages or liabilities, joint or several, to which the COMPANY or any
director or officer or any such person may become subject under the Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained, on the effective
date thereof, in any registration statement under which securities were
registered under the Act at the request of such holder, any preliminary
prospectus or final prospectus contained therein, or any amendment or
supplement thereto, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omission was made in such registration
statement, preliminary prospectus, prospectus, amendment or supplement in
reliance upon and in conformity with written information furnished to the
COMPANY through an instrument duly executed by or on behalf of such holder
specifically stating that it is for use therein; and will reimburse the
COMPANY or such director, officer or person for any legal or any other
expense reasonably incurred in connection with investigation or defending any
such loss, claim, damage, liability or action.

         3.3      Rule 144.  If the COMPANY shall be subject to the reporting
requirements of the Securities Exchange Act of 1934, as amended (the "1934
Act"), the COMPANY will use its best efforts timely to file all reports
required to be filed from time to time with the SEC (including but not
limited to the reports under Section 13 and 15(d) of the 1934 Act referred to
in subparagraph (c)(1) of Rule 144 adopted by the SEC under the Act). If
there is a public

<PAGE>

market for any securities of the COMPANY at any time that the COMPANY is not
subject to the reporting requirements of either of said Section 13 or 15(d),
the COMPANY will, upon the request of PURCHASER, use its best efforts to make
publicly available the information concerning the COMPANY referred to in
subparagraph (c)(2) of said Rule 144. The COMPANY will furnish to PURCHASER,
promptly upon request, (i) a written statement of the COMPANY's compliance
with the requirements of subparagraphs (c)(1) or (c)(2), as the case may be,
of said Rule 144, and (ii) written information concerning the COMPANY
sufficient to enable PURCHASER to complete any Form 144 required to be filed
with the SEC pursuant to said Rule 144.

                                    ARTICLE 4
                                  MISCELLANEOUS

         4.1      Entire Agreement.  This Agreement sets forth the entire
agreement and understanding of the parties hereto with respect to the
transactions contemplated hereby, and supersedes all prior agreements,
arrangements and understandings related to the subject matter hereof. No
understanding, promise, inducement, statement of intention, representation,
warranty, covenant or condition, written or oral, express or implied, whether
by statute or otherwise, has been made by any party hereto which is not
embodied in this Agreement or the written statements, certificates, or other
documents delivered pursuant hereto or in connection with the transactions
contemplated hereby, and no party hereto shall be bound by or liable for any
alleged understanding, promise, inducement, statement, representation,
warranty, covenant or condition not so set forth.

         4.2      Notices.  Any notice, request, instruction, or other
document required by the terms of this Agreement, or deemed by any of the
parties hereto to be desirable, to be given to any other party hereto shall
be in writing and shall be given by facsimile, personal delivery, overnight
delivery, or mailed by registered or certified mail, postage prepaid, with
return receipt requested, to the following addresses:

TO SELLER:        thehealthchannel.com, Inc.
5000 Birch Street, Suite 4000
Newport Beach, California 92660
Fax: (949) 260-2099
Attn: Mr. Thomas F. Lonergan, Secretary/Treasurer

TO PURCHASER:
_____________________________
_____________________________
_____________________________
Fax: (___) __________________
Attn:________________________

WITH COPY TO:

HORWITZ & BEAM
Two Venture Plaza, Suite 350
Irvine, CA 92618
Fax: (949) 453-9416
Attn: Lynne Bolduc, Esq.

The persons and addresses set forth above may be changed from time to time by
a notice sent as aforesaid. If notice is given by facsimile, personal
delivery, or overnight delivery in accordance with the provisions of this
Section, said notice shall be conclusively deemed given at the time of such
delivery. If notice is given by mail in accordance with the provisions of
this Section, such notice shall be conclusively deemed given seven days after
deposit thereof in the United States mail.

         4.3      Waiver and Amendment.  Any term, provision, covenant,
representation, warranty or condition of this Agreement may be waived, but
only by a written instrument signed by the party entitled to the benefits
thereof. The failure or delay of any party at any time or times to require
performance of any provision hereof or to exercise its

<PAGE>

rights with respect to any provision hereof shall in no manner operate as a
waiver of or affect such party's right at a later time to enforce the same.
No waiver by any party of any condition, or of the breach of any term,
provision, covenant, representation or warranty contained in this Agreement,
in any one or more instances, shall be deemed to be or construed as a further
or continuing waiver of any such condition or breach or waiver of any other
condition or of the breach of any other term, provision, covenant,
representation or warranty. No modification or amendment of this Agreement
shall be valid and binding unless it be in writing and signed by all parties
hereto.

         4.4      Choice of Law.  This Agreement and the rights of the
parties hereunder shall be governed by and construed in accordance with the
laws of the State of California including all matters of construction,
validity, performance, and enforcement and without giving effect to the
principles of conflict of laws.

         4.5      Jurisdiction.  The parties submit to the jurisdiction of
the Courts of the County of Orange, State of California or a Federal Court
empaneled in the State of California for the resolution of all legal disputes
arising under the terms of this Agreement, including, but not limited to,
enforcement of any arbitration award.

         4.6      Counterparts.  This Agreement may be executed in one or
more counterparts, each of which shall be deemed an original, but all of
which shall together constitute one and the same instrument.

         4.7      Attorneys' Fees.  Except as otherwise provided herein, if a
dispute should arise between the parties including, but not limited to
arbitration, the prevailing party shall be reimbursed by the non-prevailing
party for all reasonable expenses incurred in resolving such dispute,
including reasonable attorneys' fees exclusive of such amount of attorneys'
fees as shall be a premium for result or for risk of loss under a contingency
fee arrangement.

         4.8      Taxes.  Any income taxes required to be paid in connection
with the payments due hereunder, shall be borne by the party required to make
such payment. Any withholding taxes in the nature of a tax on income shall be
deducted from payments due, and the party required to withhold such tax shall
furnish to the party receiving such payment all documentation necessary to
prove the proper amount to withhold of such taxes and to prove payment to the
tax authority of such required withholding.

                             SIGNATURE PAGE FOLLOWS

<PAGE>

         IN WITNESS WHEREOF, the parties hereto have executed this Agreement,
as of the date first written hereinabove.

PURCHASER

_____________________________________

By: __________________________________
Its:__________________________________

SELLER

THEHEALTHCHANNEL, INC.
a Delaware corporation

By:  Thomas F. Lonergan
Its: Secretary and Treasurer

<PAGE>

                                WARRANT AGREEMENT

         THIS WARRANT AGREEMENT (this "Agreement") is made and entered into
as of _______________, 1999, between THEHEALTHCHANNEL.COM, INC., a Delaware
corporation (the "Company") and _______________________________ ("Holder").

                                 R E C I T A L S

         WHEREAS, the Company proposes to issue to Holder ______ warrants
(the "Warrants"), each such Warrant entitling the holder thereof to purchase
one share of Common Stock of the Company (the "Exercise Shares," "Shares," or
the "Common Stock"); and

         WHEREAS, the Warrants which are the subject of this Agreement will
be issued by the Company to Holder as part of consideration payable to Holder
in connection with an investment by the Holder pursuant to the concurrent
private offering of the Company (the "Offering").

         NOW, THEREFORE, in consideration of the premises and the mutual
agreements herein set forth, the parties hereto agree as follows:

                                A G R E E M E N T

         1.       Warrant Certificates.  The warrant certificates to be
delivered pursuant to this Agreement (the "Warrant Certificates") shall be in
the form set forth in Exhibit A, attached hereto and made a part hereof, with
such appropriate insertions, omissions, substitutions and other variations as
are required or permitted by this Warrant Agreement.

         2.       Right to Exercise Warrants.  Each Warrant may be exercised
from the date of this Agreement until 11:59 P.M. (Pacific time) on the date
that is two years after the date of this Agreement (the "Expiration Date").
Each Warrant not exercised on or before the Expiration Date shall expire.

Each Warrant shall entitle its holder to purchase from the Company one share
of Common Stock at an exercise price of $0.75 per share, subject to
adjustment as set forth below ("Exercise Price").

The Company shall not be required to issue fractional shares of capital stock
upon the exercise of this Warrant or to deliver Warrant Certificates which
evidence fractional shares of capital stock. In the event that a fraction of
an Exercise Share would, except for the provisions of this paragraph 2, be
issuable upon the exercise of this Warrant, the Company shall pay to the
Holder exercising the Warrant an amount in cash equal to such fraction
multiplied by the current market value of the Exercise Share. For purposes of
this Agreement, the current market value shall be determined as follows:

                  (a)      if the Exercise Shares are traded in the
over-the-counter market and not on any national securities exchange and not
in the NASDAQ Reporting System, the average of the mean between the last bid
and asked prices per share, as reported by the National Quotation Bureau,
Inc., or an equivalent generally accepted reporting service, for the last
business day prior to the date on which this Warrant is exercised, or, if not
so reported, the average of the closing bid and asked prices for an Exercise
Share as furnished to the Company by any member of the National Association
of Securities Dealers, Inc., selected by the Company for that purpose.

                  (b)      if the Exercise Shares are listed or traded on a
national securities exchange or in the NASDAQ Reporting System, the closing
price on the principal national securities exchange on which they are so
listed or traded or in the NASDAQ Reporting System, as the case may be, on
the last business day prior to the date of the exercise of this Warrant. The
closing price referred to in this Clause (b) shall be the last reported sales
price or, in case no such reported sale takes place on such day, the average
of the reported closing bid and asked prices, in either case on the national
securities exchange on which the Exercise Shares are then listed or in the
NASDAQ Reporting System; or

<PAGE>

                  (c)      if no such closing price or closing bid and asked
prices are available, as determined in any reasonable manner as may be
prescribed by the Board of Directors of the Company.

         3.       Mutilated or Missing Warrant Certificates.  In case any of
the Warrant Certificates shall be mutilated, lost, stolen or destroyed prior
to its expiration date, the Company shall issue and deliver, in exchange and
substitution for and upon cancellation of the mutilated Warrant Certificate,
or in lieu of and in substitution for the Warrant Certificate lost, stolen or
destroyed, a new Warrant Certificate of like tenor and representing an
equivalent right or interest.

         4.       Reservation of Shares.  The Company will at all times
reserve and keep available, free from preemptive rights, out of the aggregate
of its authorized but unissued Shares or its authorized and issued Shares
held in its treasury for the purpose of enabling it to satisfy its obligation
to issue Shares upon exercise of Warrants, the full number of Shares
deliverable upon the exercise of all outstanding Warrants.

The Company covenants that all Shares which may be issued upon exercise of
Warrants will be validly issued, fully paid and nonassessable outstanding
Shares of the Company.

         5.       Rights of Holder.  The Holder shall not, by virtue of
anything contained in this Warrant Agreement or otherwise, prior to exercise
of this Warrant, be entitled to any right whatsoever, either in law or
equity, of a stockholder of the Company, including without limitation, the
right to receive dividends or to vote or to consent or to receive notice as a
shareholder in respect of the meetings of shareholders or the election of
directors of the Company of any other matter.

         6.       Investment Intent.  Holder represents and warrants to the
Company that Holder is acquiring the Warrants for investment and with no
present intention of distributing or reselling any of the Warrants.

         7.       Certificates to Bear Language.  The Warrants and the
certificate or certificates therefor shall bear the following legend by which
each holder shall be bound:

"THE WARRANTS REPRESENTED BY THIS CERTIFICATE AND THE SHARES OF COMMON STOCK
(OR OTHER SECURITIES) ISSUABLE UPON EXERCISE THEREOF HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933. THE SHARES MAY NOT BE SOLD OR TRANSFERRED
IN THE ABSENCE OF SUCH REGISTRATION OR TRANSFERRED IN THE ABSENCE OF SUCH
REGISTRATION OR AN OPINION OF COUNSEL THAT AN EXEMPTION FROM REGISTRATION
UNDER SUCH ACT IS AVAILABLE."

The Shares and the certificate or certificates evidencing any such Shares
shall bear the following legend:

"THE SHARES (OR OTHER SECURITIES) REPRESENTED BY THIS CERTIFICATE HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THE SHARES MAY NOT BE SOLD
OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL
THAT AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT IS AVAILABLE."

Certificates for Warrants without such legend shall be issued if such
warrants or shares are sold pursuant to an effective registration statement
under the Securities Act of 1933 (the "Act") or if the Company has received
an opinion from counsel reasonably satisfactory to counsel for the Company,
that such legend is no longer required under the Act.

         8.       Piggyback Registration Rights.  If the Company at any time
proposes to register any of its securities under the Act, including under an
SB-2 Registration Statement or otherwise, the Company will use its best
efforts to cause all of the shares of common stock underlying the Warrants
owned by Holder to be registered under the Act (with the securities which the
Company at the time propose to register), all to the extent requisite to
permit the sale or other disposition by the Holder; provided, however, that
the Company may, as a condition precedent to its effecting such registration,
require the Holder to agree with the Company and the managing underwriter or
underwriters of the offering to be made by the Company in connection with
such registration that the Holder will not sell any securities of the same
class or convertible into the same class as those registered by the Company
(including any class into which the securities registered by the Company are
convertible) for such reasonable period after such registration becomes

<PAGE>

effective as shall then be specified in writing by such underwriter or
underwriters if in the opinion of such underwriter or underwriters the
Company's offering would be materially adversely affected in the absence of
such an agreement. All expenses incurred by the Company in complying with
this Section, including without limitation all registration and filing fees,
listing fees, printing expenses, fees and disbursements of all independent
accounts, or counsel for the Company and or counsel for the Holder and the
expense of any special audits incident to or required by any such
registration and the expenses of complying with the securities or blue sky
laws of any jurisdiction shall be paid by the Company. Notwithstanding the
foregoing, Holder shall pay all underwriting discounts or commissions with
respect to any securities sold by the Holder.

                  (a)      Indemnification.

                           (i)      In the event of any registration of any
of its securities under the Act pursuant to this Section, the Company hereby
indemnifies and holds harmless the Holder (which phrase shall include any
underwriters of such securities), their respective directors and officers,
and each other person who participates, in the offering of such securities
and each other person, if any, who controls the Holder, or such participating
persons within the meaning of the Act, against any losses, claims, damages or
liabilities, joint or several, to which each the Holder or any such director
or officer or participating person or controlling person may become subject
under the Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon
any untrue statement or alleged untrue statement of any material fact
contained, on the effective date thereof, in any registration statement under
which such securities were registered under the Act, any preliminary
prospectus or final prospectus contained therein, or any amendment or
supplement thereto, or arise out of or are based upon any omission or alleged
omission to state therein an material fact required to be stated therein or
necessary to make the statements therein not misleading; and will reimburse
each the Holder and each director, officer or participating or controlling
person for any legal or any other expenses reasonably incurred by the Holder
or such director, officer or participating or controlling person in
connection with investigating or defending any such loss, claim, damage,
liability or action; provided, however, that the Company shall not be liable
in any such case to the extent that any such loss, claim, damage or liability
arises out of is based upon an untrue statement or alleged untrue statement
or omission or alleged omission made in such registration statement,
preliminary prospectus or prospectus or amendment or supplement in reliance
upon and in conformity with written information furnished to the Company
through an instrument duly executed by the Holder specifically stating that
it is for use therein. Such indemnity shall remain in full force and effect
regardless of any investigation made by or on behalf of the Holder or such
directors, officer or participating or controlling person, and shall survive
the transfer of such securities by the Holder.

                           (ii)     The Holder shall by acceptance thereof,
indemnify and hold harmless the Company and its directors and officers, and
each person, if any who controls the Company, against any losses, claims,
damages or liabilities, joint or several, to which the Company or any
director or officer or any such person may become subject under the Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained, on the effective
date thereof, in any registration statement under which securities were
registered under the Act at the request of such holder, any preliminary
prospectus or final prospectus contained therein, or any amendment or
supplement thereto, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omission was made in such registration
statement, preliminary prospectus, prospectus, amendment or supplement in
reliance upon and in conformity with written information furnished to the
Company through an instrument duly executed by or on behalf of such holder
specifically stating that it is for use therein; and will reimburse the
Company or such director, officer or person for any legal or any other
expense reasonably incurred in connection with investigation or defending any
such loss, claim, damage, liability or action.

                  (b)      Rule 144.  If the Company shall be subject to the
reporting requirements of the Securities Exchange Act of 1934, as amended
(the "1934 Act"), the Company will use its best efforts timely to file all
reports required to be filed from time to time with the SEC (including but
not limited to the reports under Section 13 and 15(d) of the 1934 Act
referred to in subparagraph (c)(1) of Rule 144 adopted by the SEC under the
Act). If there is a public market for any securities of the Company at any
time that the Company is not subject to the reporting requirements of either
of said Section 13 or 15(d), the Company will, upon the request of Holder,
use its best efforts to make publicly

<PAGE>

available the information concerning the Company referred to in subparagraph
(c)(2) of said Rule 144. The Company will furnish to Holder, promptly upon
request, (i) a written statement of the Company's compliance with the
requirements of subparagraphs (c)(1) or (c)(2), as the case may be, of said
Rule 144, and (ii) written information concerning the Company sufficient to
enable Holder to complete any Form 144 required to be filed with the SEC
pursuant to said Rule 144.

         9.       Adjustment of Number of Shares and Class of Capital Stock
Purchasable.  The Number of Shares and Class of Capital Stock purchasable
under this Warrant Agreement are subject to adjustment from time to time as
set forth in this Section.

                  (a)      Adjustment for Change in Capital Stock. If the
Company:

                           (i)      pays a dividend or makes a distribution
on its Common Stock, in each case, in shares of its Common Stock;

                           (ii)     subdivides its outstanding shares of
Common Stock into a greater number of shares;

                           (iii)    combines its outstanding shares of Common
Stock into a smaller number of shares;

                           (iv)     makes a distribution on its Common Stock
in shares of its capital stock other than Common Stock; or

                           (v)      issues by reclassification of its shares
of Common Stock any shares of its capital stock;

then the number and classes of shares purchasable upon exercise of each
Warrant in effect immediately prior to such action shall be adjusted so that
the holder of any Warrant thereafter exercised may receive the number and
classes of shares of capital stock of the Company which such holder would
have owned immediately following such action if such holder had exercised the
Warrant immediately prior to such action.

For a dividend or distribution the adjustment shall become effective
immediately after the record date for the dividend or distribution. For a
subdivision, combination or reclassification, the adjustment shall become
effective immediately after the effective date of the subdivision,
combination or reclassification.

If after an adjustment the holder of a Warrant upon exercise of it may
receive shares of two or more classes of capital stock of the Company, the
Board of Directors of the Company shall in good faith determine the
allocation of the adjusted Exercise Price between or among the classes of
capital stock. After such allocation, that portion of the Exercise Price
applicable to each share of each such class of capital stock shall thereafter
be subject to adjustment on terms comparable to those applicable to Common
Stock in this Agreement. Notwithstanding the allocation of the Exercise Price
between or among shares of capital stock as provided by this Section 9(a), a
Warrant may only be exercised in full by payment of the entire Exercise Price
currently in effect.

                  (b)      Consolidation, Merger or Sale of the Company.  If
the Company is a party to a consolidation, merger or transfer of assets which
reclassifies or changes its outstanding Common Stock, the successor
corporation (or corporation controlling the successor corporation or the
Company, as the case may be) shall by operation of law assume the Company's
obligations under this Warrant Agreement. Upon consummation of such
transaction the Warrants shall automatically become exercisable for the kind
and amount of securities, cash or other assets which the holder of a Warrant
would have owned immediately after the consolidation, merger or transfer if
the holder had exercised the Warrant immediately before the effective date of
such transaction. As a condition to the consummation of such transaction, the
Company shall arrange for the person or entity obligated to issue securities
or deliver cash or other assets upon exercise of the Warrant to, concurrently
with the consummation of such transaction, assume the Company's obligations
hereunder by executing an instrument so providing and further providing for
adjustments which shall be as nearly equivalent as may be practical to the
adjustments provided for in this Section 9.

<PAGE>

         10.      Successors.  All the covenants and provisions of this
Agreement by or for the benefit of the Company or Holder shall bind and inure
to the benefit of their respective successor and assigns hereunder.

         11.      Counterparts.  This Agreement may be executed in any number
of counterparts and each of such counterparts shall for all proposes be
deemed to be an original, and such counterparts shall together constitute by
one and the same instrument.

         12.      Notices.  Any notice, request, instruction, or other
document required by the terms of this Agreement, or deemed by any of the
parties hereto to be desirable, to be given to any other party hereto shall
be in writing and shall be given by facsimile, personal delivery, overnight
delivery, or mailed by registered or certified mail, postage prepaid, with
return receipt requested, to the following addresses:

TO SELLER:        thehealthchannel.com, Inc.
5000 Birch Street, Suite 4000
Newport Beach, California 92660
Fax: (949) 260-2099
Attn: Mr. Thomas F. Lonergan, Secretary/Treasurer

TO HOLDER:        ___________________________
_____________________________________
_____________________________________
Fax: (___) __________________________
Attn:________________________________

WITH COPY TO:
HORWITZ & BEAM
Two Venture Plaza, Suite 350
Irvine, CA 92715
Fax: (949) 453-9416
Attn: Lynne Bolduc, Esq.

The persons and addresses set forth above may be changed from time to time by
a notice sent as aforesaid. If notice is given by facsimile, personal
delivery, or overnight delivery in accordance with the provisions of this
Section, said notice shall be conclusively deemed given at the time of such
delivery. If notice is given by mail in accordance with the provisions of
this Section, such notice shall be conclusively deemed given seven days after
deposit thereof in the United States mail.

         13.      Supplements and Amendments.  The Company may from time to
time supplement or amend this Warrant Agreement without the approval of any
Holders of Warrants in order to cure any ambiguity or to be correct or
supplement any provision contained herein which may be defective or
inconsistent with any other provision, or to make any other provisions in
regard to matters or questions herein arising hereunder which the Company may
deem necessary or desirable and which shall not materially adversely affect
the interest of the Holder.

         14.      Severability.  If for any reason any provision, paragraph
or term of this Warrant Agreement is held to be invalid or unenforceable, all
other valid provisions herein shall remain in full force and effect and all
terms, provisions and paragraphs of this Warrant shall be deemed to be
severable.

         15.      Governing Law and Venue.  This Warrant shall be deemed to
be a contract made under the laws of the State of California and for all
purposes shall be governed and construed in accordance with the laws of said
State. Any proceeding arising under this Warrant Agreement shall be
instituted in the County of Orange, State of California.

         16.      Headings.  Paragraphs and subparagraph headings, used
herein are included herein for convenience of reference only and shall not
affect the construction of this Warrant Agreement nor constitute a part of
this Warrant Agreement for any other purpose.

<PAGE>

         IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be duly executed, as of the date and year first above written.

"COMPANY"

THEHEALTHCHANNEL.COM, INC.

_____________________________________
BY: Thomas F. Lonergan
ITS: Secretary/Treasurer

"HOLDER"

_____________________________________

_____________________________________
By: _________________________________

Its:_________________________________

<PAGE>

                                    EXHIBIT A
                                NUMBER __ WARRANT
                               WARRANT TO PURCHASE

                                     Shares

THEHEALTHCHANNEL.COM, INC. see reverse for COMMON STOCK PURCHASE WARRANT
certain definitions will be void if not exercised prior to 11:59 P.M. Pacific
Time on __________, ____. This Certifies that for value received, the
registered holder or assigns ("Holder"), is entitled to purchase from
thehealthchannel.com, Inc., a Delaware corporation (the "Company") at any
time after 9:00 A.M. Pacific Time on __________, ____ at the purchase price
per share of $0.75 (the "Warrant Price"), the number of shares of Common
Stock of the Company set forth above (the "Shares"). The number of shares
purchasable upon exercise of each warrant evidenced hereby and the Warrant
Price per Share shall be subject to adjustment from time to time as set forth
in the Warrant Agreement referred to below. The Warrants expire on
__________, ____. Holders will not have any rights or privileges of
shareholders of the Company prior to exercise of the Warrants. Holders of the
Warrants evidenced hereby and the shares of Common Stock issuable upon
exercise hereof have certain rights with respect to registration with the
Securities and Exchange Commission of the Warrants and Common Stock issuable
upon exercise hereof. These registration rights are set forth in that certain
Warrant Agreement of even date herewith pursuant to which this Warrant
Certificate has been issued. The Warrant evidenced hereby may be exercised in
whole or in part by presentation of this Warrant certificate with the
Purchase Form on the reverse side hereof fully executed (with a signature
guarantee as provided on the reverse side hereof) and simultaneous payment of
the Warrant Price (subject to adjustment) at the principal office of the
Company. Payment of such price shall be made at the option of the Holder in
cash or by certified check or bank draft. The Warrants evidenced hereby are
part of a duly authorized issue of Common Stock Purchase Warrants with rights
to purchase an aggregate of up to 5,000,000 shares of Common Stock of the
Company. Upon any partial exercise of the Warrant evidenced hereby, there
shall be countersigned and issued to the Holder a new Warrant Certificate in
respect of the Shares as to which the Warrants evidenced hereby shall not
have been exercised. This Warrant Certificate may be exchanged at the office
of the Company by surrender of this Warrant Certificate properly endorsed
with a signature guarantee either separately or in combination with one or
more other Warrants for one or more new Warrants to purchase the same
aggregate number of Shares as evidenced by the Warrant or Warrants exchanged.
No fractional Shares will be issued upon the exercise of rights to purchase
hereunder, but the Company shall pay the cash value of any fraction upon the
exercise of one or more Warrants. The Holder hereof may be treated by the
Company and all other persons dealing with this Warrant Certificate as the
absolute owner hereof for all purposes and as the person entitled to exercise
the rights represented hereby, any notice to the contrary notwithstanding,
and until such transfer is on such books, the Company may treat the Holder as
the owner for all purposes.

Dated: __________, ____                              THEHEALTHCHANNEL.COM, INC.

Secretary                                               Chief Executive Officer

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF
CERTAIN STATES, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED,
HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO
THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE
ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF
COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE
ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE
STATE LAW IS AVAILABLE.

<PAGE>

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF
CERTAIN STATES, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED,
HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO
THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE
ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF
COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE
ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE
STATE LAW IS AVAILABLE.

                              ELECTION TO PURCHASE

The undersigned hereby elects irrevocably to exercise the within Warrant and
to purchase _______________________ shares of Common Stock of
thehealthchannel.com, Inc. and hereby makes payment of $_________ (at the
rate of $________ per share) in payment of the Exercise Price pursuant
hereto. Please issue the shares as to which this Warrant is exercised in
accordance with the instructions given below.

The undersigned represents and warrants that the exercise of the within
Warrant was solicited by the member firm of the National Association of
Securities Dealers, Inc. ("NASD") listed below. If not solicited by an NASD
member, please write "unsolicited" in the space below.

<PAGE>

_____________________________________________
(Insert Name of NASD Member or "Unsolicited")

Dated: ________________________     Signature: ________________________________

                     INSTRUCTIONS FOR REGISTRATION OF SHARES

Name (print) __________________________________________________________________

Address (print) _______________________________________________________________

                                   ASSIGNMENT

FOR VALUE RECEIVED, _______________________________________________ does hereby
sell, assign and transfer unto _______________________________________________,
the right to purchase ________________shares of Common Stock of
thehealthchannel.com, Inc., evidenced by the within Warrant, and does hereby
irrevocably constitute and appoint __________________________________________
attorney to transfer such right on the books of thehealthchannel.com, Inc.,
with full power of substitution on the premises.

Dated: ________________, 19______

Signature: _____________________________________________

Notice: The signature of Election to Purchase or Assignment must correspond
with the name as written upon the face of the within Warrant in every
particular without alteration or enlargement or any change whatsoever. The
signature(s) must by guaranteed by an eligible guarantor institution (Banks,
Stockbrokers, Savings and Loan Associations and Credit Unions with membership
in an approved signature guarantee Medallion Program), pursuant to S.E.C.
Rule 17Ad-15.

_____________________________________________
Signature Guarantee<PAGE>

                                  Exhibit 10.1
              Acquisition, Stock Purchase, and Exchange Agreement,
                               dated July 28, 1999

<PAGE>

               ACQUISITION, STOCK PURCHASE AND EXCHANGE AGREEMENT

         THIS AGREEMENT, made as of the 28th day of July, 1999, is by and
between BioLogix International, Ltd., a Delaware corporation (the "PURCHASER")
and Innovative Tracking Solutions, Corporation, a Delaware corporation (the
"COMPANY"), and Dianna Cleveland, an individual, Lee Namisniak, an individual,
and Lou Weiss, an individual (collectively referred to as the "SHAREHOLDERS").

                                   WITNESSETH

         WHEREAS, the COMPANY is a publicly held Delaware corporation, traded on
the Over-the-Counter Bulletin Board under the symbol "IVTX", with a total of
10,000,000 shares of common stock authorized and 3,785,243 shares issued and
outstanding of which 1,185,243 shares are held by the public and 2,600,000
restricted shares are held by management. Of the shares held by the public,
there are approximately 410,677 Regulation D, Rule 504 free trading shares,
475,191 restricted shares that have been held more than one year and are
currently tradable under Rule 144, and 299,375 restricted shares under Rule 144
that have been held less than one year.

         WHEREAS, SHAREHOLDERS are the owners of 2,600,000 shares (the "Shares")
of the Common Stock of Innovative Tracking Solutions Corporation ("COMPANY");
and WHEREAS, PURCHASER is a publicly held Delaware corporation, traded on the
Over- the-Counter Bulletin Board under the symbol "BGIX" and is in the business
of internet healthcare information services with a total of approximately
20,000,000 freely tradable and 50,000,000 restricted shares of stock issued and
outstanding; and

         WHEREAS, SHAREHOLDERS desire to sell 2,550,000 Shares to the PURCHASER
on the terms and conditions set forth in this Acquisition, Stock Purchase and
Exchange Agreement (hereinafter called "Agreement"); and WHEREAS, the COMPANY
desires to acquire the majority of assets of PURCHASER, specifically, 100% of
the proprietary website, "thehealthchannel.com" and related technology (the
"WEBSITE"), in exchange for the majority of outstanding common stock of COMPANY;
and

         WHEREAS, the PURCHASER desires the COMPANY to conduct a forward split
of its current outstanding stock in order to facilitate a 1 to 1 exchange of
outstanding shares of PURCHASER for shares of COMPANY and to facilitate a 2 to 1
forward exchange of outstanding shares of COMPANY to COMPANY's shareholders
(hereinafter referred to as the "SHARE EXCHANGE PLAN"); and

         WHEREAS, it is the intention of the parties that the transactions
completed hereby shall to the extent possible, be structured as a tax deferred
exchange and reorganization, as defined in the Internal Revenue Code of 1986,
resulting in no adverse tax liability to the SHAREHOLDERS, the COMPANY, the
PURCHASER and that all the terms of the Agreement shall be interpreted,
construed and enforced to effectuate this intent.

         NOW THEREFORE, in consideration of the promises and respective mutual
agreements herein contained, it is agreed by and between the parties hereto as
follows:

                                    AGREEMENT

         1) Sale of the Shares. Upon the execution of this Agreement as provided
in Section 2 hereto (the "Closing"), subject to the terms and conditions herein
set forth, and on the basis of the representations, warranties and agreements
herein contained, SHAREHOLDERS shall sell to PURCHASER, and

PURCHASER shall purchase from SHAREHOLDERS, the Shares.

                  a) Instruments of Conveyance and Transfer. Within fifteen (15)
days of the Closing, SHAREHOLDERS shall deliver certificates representing the
Shares to the Custodian, Horwitz & Beam, for further delivery to the PURCHASER,
in form and substance satisfactory to PURCHASER, as shall be effective to vest
in PURCHASER all right, title and interest in and to all of the Shares, as set
forth in Section 3 herein.

<PAGE>

                  b) Consideration and Payment for the Shares. In consideration
for the Shares PURCHASER shall pay the purchase price equal to $250,000
("Purchase Price"), receipt of which is acknowledged.

         2) Closing. The Closing shall be deemed to have occurred upon the date
of signing of this Agreement. Following the closing, subsequent actions by the
parties as provided in Section 3 hereto shall occur in a timely manner.

         3) Subsequent Actions of SHAREHOLDERS

                  a) SHAREHOLDERS shall deliver to the Custodian for further
delivery to the PURCHASER stock certificates and any and all other instruments
of conveyance and transfer required by Section 1 hereto.

                  b) SHAREHOLDERS shall deliver, or cause to be delivered, to
the Custodian for further delivery to the PURCHASER such instruments, documents
and certificates as are required to be delivered by SHAREHOLDERS or its
representatives pursuant to the provisions of this Agreement.

         4) Subsequent Actions of CUSTODIAN

                  a) Upon the delivery of the Shares by SHAREHOLDERS to the
CUSTODIAN, the CUSTODIAN shall hold, administer and distribute the Shares to
PURCHASER pursuant to the terms of this Agreement upon the closing of this
Agreement or another mutually agreeable date.

         5) Subsequent Actions of COMPANY

                  a) The COMPANY shall cancel all issued securities options
convertible into IVTX shares as requested by PURCHASER.

                  b) The COMPANY shall change its name to "thehealthchannel.com,
Inc." and increase its authorized capital stock to one hundred ten million
(110,000,000) shares of common stock.

                  c) The COMPANY shall implement a forward stock split of 28.22
to 1 of all outstanding IVTX shares of record as of July 29, 1999 resulting in a
total of approximately 106,819,558 shares outstanding consisting of 24,999,195
tradable shares and 81,820,362 restricted shares in order to bring its current
outstanding shares to a level that will facilitate an exchange of shares with
the total outstanding shares of PURCHASER. The split shall not be intended to
effect the current trading price of IVTX on the record date. The post-split
shares are hereinafter referred to as the "THCL" shares.

The post-split shares are intended to be allocated as follows:

<TABLE>
       <S>      <C>                 <C>
       1.        20,000,000         Tradable shares for PURCHASER's public float (1:1 exchange); and

       2.        81,221,614         Restricted shares for PURCHASER's restricted shareholders, treasury and
                                    contingencies; and

       3.         3,127,458         Tradable shares for PURCHASER's treasury for contingencies; and

       4.         1,771,736         Tradable shares for COMPANY's public tradable float (2:1 exchange);

       5.           598,750         Restricted shares for COMPANY's restricted public shareholders, excluding
                                    management (2:1 exchange); and

       6.           100,000         Shares to IVTX management (2:1 exchange).
                  ---------
                106,819,558         Total Outstanding Shares
</TABLE>

The extra restricted stock not used will be cancelled by PURCHASER and/or
utilized in a private placement, at the discretion of PURCHASER.

<PAGE>

                  d) The COMPANY shall authorize its transfer agent to forward
and release all shareholder lists and relevant records to the PURCHASER's
transfer agent following the forward split.

                  e) The COMPANY shall assist PURCHASER in responding to any
comments received relative to the COMPANY'S Form 10-SB disclosure document filed
with the Securities and Exchange Commission ("SEC") on December 14, 1998 (the
"Form 10- SB), including any amendments thereto.

                  f) Upon the final completion of the Acquisition and Share
Exchange Plan, the COMPANY's Board of Directors and Officers will resign said
directorships and offices and, by a duly authorized resolution prior to their
resignation, shall appoint Don Shea as President and Director, and Thomas F.
Lonergan as Secretary, Treasurer and Director of the COMPANY.

                  g) The COMPANY shall deliver, or cause to be delivered, to the
Custodian for further delivery to the PURCHASER such instruments, documents and
certificates as are required to be delivered by COMPANY or its representatives
pursuant to the provisions of this Agreement and copies of all corporate records
and securities filings in the COMPANY's possession.

                  h) The COMPANY shall notify its shareholders as to the details
of this Agreement and require its shareholders to make their final elections for
options previously given to its shareholders to exchange their IVTX shares into
private shares of Innovative Tracking Solutions Corporation, a private Nevada
Corporation, (hereinafter referred to as "ITSC PRIVATE SHARES"), and to finalize
all exchanges and transfers in a timely manner. The parties to this Agreement
understand that prior to the signing of this Agreement, the COMPANY estimated
that all but 325,000 IVTX shares held by COMPANY's public shareholders would be
submitted for exchange into ITSC PRIVATE SHARES. The parties further understand
that this estimate was based on the elections for exchange previously submitted
by the COMPANY's shareholders based on the COMPANY'S intention to merge with
Desert Sun Investments, Ltd. and prior to the notification to COMPANY's
shareholders of the proposed acquisition of "thehealthchannel.com" and the terms
of this Agreement. The parties to this Agreement understand that after
notification to the COMPANY's shareholders by COMPANY of the terms of this
Agreement, that the COMPANY is obligated to allow its shareholders to change
their elections for exchange of IVTX shares into ITSC PRIVATE SHARES, and that
said elections will undoubtedly change. The parties understand that said changes
in elections could result in as much as 100% of IVTX shares held by the
COMPANY'S public shareholders remaining unxchanged for ITSC PRIVATE SHARES and
that all un-exchanged IVTX shares that remain to be held by the COMPANY'S
shareholders, including 50,000 shares retained by COMPANY's current management,
shall be split, and upon surrender, shall be exchangeable into THCL shares on a
basis of two shares of THCL for each IVTX post-split share held.

                  i) The COMPANY shall use its best efforts to secure from each
IVTX shareholder of record as of July 29, 1999 a signed affidavit that releases
all claim and title to 26.22 post-split shares pursuant to the SHARE EXCHANGE
PLAN thereby allowing said post-split shares to be exchanged on a 1 to 1 basis
with BGIX shareholders while resulting in a 2 to 1 forward exchange for
COMPANY's shareholders

                  j) The COMPANY shall use its best efforts to coordinate the
sale of all shares held in THCL by the COMPANY's existing shareholders,
including shares retained by COMPANY's management, in a manner that minimizes
the number of shares being sold in the market to approximately 10% per month of
the total olders over a period of ten (10) consecutive months following the date
of this Agreement. The arties understand that any shares held by COMPANY's
existing management or affiliated parties shall not be tradable for a minimum of
ninety (90) days following the execution of this Agreement but that the monthly
limitation shall still expire ten (10) months from the date of this Agreement.
The parties to this Agreement understand that no assurance can be given that the
monthly limitation will be achieved, and if not achieved, shall not constitute a
breach of this Agreement.

         6) Subsequent Actions of PURCHASER.

                  a) The PURCHASER shall deliver the Purchase Price as required
in Section 1(b) of this Agreement.

<PAGE>

                  b) The PURCHASER shall deliver, or cause to be delivered, to
SHAREHOLDERS and COMPANY such instruments, documents and certificates as are
required to be delivered by the PURCHASER or its representatives pursuant to the
provisions of this Agreement.

                  c) The PURCHASER shall transfer its WEBSITE to the COMPANY.

                  d) The PURCHASER shall handle the redistribution of all THCL
shares as follows: each free-trading BGIX share submitted for exchange by a BGIX
shareholder shall be exchanged for one TRADABLE THCL SHARE and each restricted
BGIX share submitted for exchange by a BGIX shareholder shall be exchanged for
one restricted THCL share. Each free trading IVTX share, held as of record date
of July 29, 1999, submitted for exchange by an IVTX shareholder shall be
exchanged for two TRADABLE THCL SHARES and each IVTX restricted share, held as
of record date of July 29, 1999, submitted for exchange by an IVTX shareholder
shall be exchanged for two restricted THCL shares. All IVTX shares that bear a
restricted legend that are submitted for exchange into THCL shares shall be
exchanged for certificates of THCL that are time-stamped with the original issue
date of the IVTX shares, thereby not commencing a new holding period. However,
it is understood that the foregoing exchange of restricted BGIX shares into THCL
restricted shares may recommence the holding period for said shares.

                  e) The PURCHASER shall bear the sole responsibility of
conducting all transactions for exchange by way of a proper registration or
appropriate exemption.

                  f) The PURCHASER agrees that all transfer agent costs incurred
for both the PURCHASER'S and the COMPANY's transfer agents relative to this
Agreement, IVTX, BGIX and THCL, shall be the sole responsibility of the
PURCHASER.

                  g) The PURCHASER shall cancel all extra THCL shares at a
future date that is mutually agreeable to all the parties of this Agreement.

                  h) The PURCHASER shall include feature product coverage of the
Private Practice" Vibration Reminder Disk product line and programs on the
"thehealthchannel.com" website each month for at least six months with banner
ads at least five days per month. The PURCHASER also agrees to include video
streaming of the feature segment of the Private Practice" Vibration Reminder
Disk which will air on an upcoming edition of American Medical Review (AMR) on
National Public Television upon the approval of AMR.

         7) Representations and Warranties of SHAREHOLDERS

                  a) Validity of SHAREHOLDERS' Shares. The Shares to be
delivered to PURCHASER hereunder from the SHAREHOLDERS have been duly authorized
by the appropriate corporate action of COMPANY.

                  b) Clean Title of the Shares. The SHAREHOLDERS shall transfer
title, in and to the Shares to PURCHASER free and clear of all liens, security
interests, pledges, encumbrances, charges, restrictions, demands and claims, of
any kind and nature whatsoever, whether direct or indirect or contingent.

                  c) Delivery of the Shares. SHAREHOLDERS shall deposit with the
Custodian, certificates in fully transferable form with Medallion Signature
Guaranteed signatures representing the Shares subject to no liens, security
interests, pledges, encumbrances, charges, restrictions, demands or claims in
any other party whatsoever, except as set forth in the legend on the
certificate, which legend shall provide as follows:

THE SHARES (OR OTHER SECURITIES) REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SHARES MAY NOT BE
SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL
THAT AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT IS AVAILABLE.

                  d) Restricted Shares. PURCHASER acknowledges that the Shares
are "restricted securities" (as such term is defined in Rule 144 ("Rule 144")
promulgated under the Securities Act of 1933, as amended (the "Act"), that

<PAGE>

the Shares may include the foregoing restrictive legend, and, except as
otherwise set forth in this Agreement, that the Shares cannot be sold except
in accordance with Rule 144 promulgated by the Securities and Exchange
Commission, or unless registered with the SEC and qualified by auditors, or
unless PURCHASER otherwise complies with an exemption from such registration
and qualification (including, without limitation, compliance with Rule 144).

         8) Representations and Warranties of the COMPANY.

                  a) Organization. COMPANY is a corporation duly organized,
validly existing, and in good standing under the laws of Delaware, has all
necessary corporate powers to own properties and to carry on its business as now
owned and operated by it, is duly qualified to do business and is in good
standing in each of the jurisdictions where its business requires qualification.
COMPANY is currently in good standing with its Transfer Agent, Atlas Stock
Transfer.

                  b) Authority. The Board of Directors of COMPANY have
authorized the execution of this Agreement and the transactions contemplated
herein and has full power and authority to execute, deliver, and perform this
Agreement based on a unanimous vote of shareholders obtained at a meeting duly
convened on April 12, 1999.

                  c) Capital. The authorized capital stock of COMPANY consists
of 10,000,000 shares of $.001 par value common stock of which 3,785,243 shares
are currently issued and outstanding. All of the issued and outstanding shares
are validly issued, fully paid, and non-assessable. All currently outstanding
shares of COMPANY'S common stock have been issued in compliance with applicable
federal and state securities laws.

                  d) Subsidiaries. COMPANY has no subsidiaries and does not own
any interest in any other enterprise, whether or not enterprise is a
corporation.

                  e) Directors and Officers. The COMPANY's Form 10-SB, as filed
with the SEC on December 14, 1998, including all amendments thereto, contains
the names and titles of all officers and directors of COMPANY as of the date of
this Agreement.

                  f) Financial Statements. The COMPANY's Form 10-SBA filed with
the SEC on April 5, 1999 includes the COMPANY's audited financial statements as
of December 31, 1998. The financial statements have been prepared in accordance
with generally accepted accounting principles and practices consistently
followed throughout the period indicated and fairly present the financial
position of COMPANY as of the dates of the balance sheets included in the
financial statements and the results of operations for the periods indicated.

                  g) Absence of Changes. Since the date of COMPANY's most recent
financial statements, the COMPANY's assets and liabilities have been transferred
to another entity. All such assets formerly owned by the COMPANY are hereby
excluded from this transaction.

                  h) Absence of Undisclosed Liabilities. As of the date of
COMPANY's most recent balance sheet, included in the Form 10-SB, it did not have
any material debt, liability or obligation of any nature, whether accrued,
absolute, contingent or otherwise, and whether due or to become due, that is not
reflected in such balance sheet.

                  i) Tax Returns.  With the times and in the manner prescribed
by law, COMPANY has filed all federal, state or local tax returns required by
law, has paid all taxes, assessments and penalties due and payable and has made
adequate provisions on its most recent balance sheet for any unpaid taxes. There
are no present disputes as to taxes of any nature payable by COMPANY.

                  j) Investigation of Financial Condition. Without in any manner
reducing or otherwise mitigating the representations contained herein,
representatives of PURCHASER shall have the opportunity to meet with COMPANY's
accountants and attorneys to discuss the financial condition of COMPANY. COMPANY
shall make available to representatives of PURCHASER all books and records of
COMPANY.

                  k) Compliance with Laws. COMPANY has complied with, and is not
in violation of, applicable federal, state or local statutes, laws and
regulations affecting its properties, securities or the operation of its
business.

<PAGE>

                  l) Litigation. COMPANY is not a party to, nor to the best of
its knowledge is there pending or threatened, any suit, action, arbitration or
legal, administrative or other proceedings, or governmental investigation
concerning its business, assets or financial condition.

                  m) Ability to Carry Out Obligations. The execution and
delivery of this Agreement by COMPANY and the performance of its obligations
hereunder will not cause, constitute, conflict with or result in (i) any breach
of the provisions of any license, indenture, mortgage, charter, instrument,
certificate of incorporation, bylaw or other agreement or instrument to which it
is a party or by which it may be bound, nor will any consents or authorizations
of any party other than those hereto be required, (ii) an event that would
permit any party to any agreement or instrument to terminate it or to accelerate
the maturity of any indebtedness or other obligation, or (iii) an event that
would result in a creation or imposition of any lien, charge, or encumbrance on
any asset.

                  n) Full Disclosure. None of the representations and warrantees
made by COMPANY herein, or in any exhibit, certificate, or memorandum furnished
or to be furnished by it or on its behalf, contains or will contain any untrue
statement of a material fact, or omits any material fact, the omission of which
would be misleading.

                  o) Assets. COMPANY has had good and marketable title to all of
its property free and clear of any and all liens, claims and encumbrances

                  p) Indemnification. COMPANY agrees to indemnify, defend and
hold harmless PURCHASER against and in respect to any and all claims, demands,
losses, costs, expenses, obligations, liabilities or damages, including
interest, penalties, and reasonable attorneys fees, incurred or suffered, which
arise out of, result from or relate to any breach of, or failure by COMPANY to
perform any of its representations, warranties, or covenants in this Agreement
or in any exhibit or other instrument furnished, or to be furnished, under this
Agreement and from any and all claims, demands, losses, costs, expenses,
obligations, liabilities, or damages which arise form activities prior to the
date of the transfer of assets from PURCHASER to COMPANY as set forth in Section
6(c).

                  q) Validity of COMPANY Shares. The Shares of COMPANY $.001 par
value common stock to be issued pursuant to this Agreement will be duly
authorized, validly issued, fully paid and nonassessable under Delaware law.

         9. Representations of Warranties of PURCHASER

                  a) Organization. PURCHASER is a corporation duly organized,
validly existing, and in good standing under the laws of Delaware, has all
necessary corporate powers to own properties and to carry on its business as now
owned and operated by it, is duly qualified to do business, and is in good
standing in each of the jurisdictions where its business requires qualification.

                  b) Capital. The authorized capital stock of PURCHASER consists
of one hundred million (100,000,000) shares of common stock of which
approximately 20,000,000 free trading shares and 50,000,000 restricted shares
are currently issued and outstanding. All of the issued and outstanding shares
are validly issued, fully paid and nonassessable.

                  c) Subsidiaries.  PURCHASER has no subsidiaries.

                  d) Directors and Officers. Don Shea, President and Thomas F.
Lonergan, Vice President, C.O.O., Secretary, and Treasurer are the officers of
the Company.

                  e) Investigation of Financial Condition. Without in any manner
reducing or otherwise mitigating the representations contained herein, COMPANY
and/or its attorneys shall have the opportunity to meet with accountants and
attorneys to discuss the financial condition of PURCHASER. PURCHASER shall make
available to COMPANY and/or its attorneys all books and records of PURCHASER.
Further, PURCHASER shall provide a copy of its most recent financial statements
to COMPANY and SHAREHOLDERS prior to the Closing. If the transaction
contemplated hereby is not completed, all documents received by COMPANY and/or
its attorneys shall be returned to PURCHASER and all information so received
shall be treated as confidential.

<PAGE>

                  f) Compliance with Laws. PURCHASER has complied with, and is
not in violation of, applicable federal, state or local statutes, laws and
regulations affecting its properties, securities or the operation of its
business.

                  g) Litigation. PURCHASER is not a party to, nor to the best of
its knowledge, is there pending or threatened, any suit, action, arbitration or
legal, administrative or other proceedings, or governmental investigation
concerning its business, assets or financial condition. PURCHASER is not in
default with respect to any order, writ, injunction or decree of any federal,
state, local, or foreign court or agency, nor is it engaged in, nor does it
anticipate it will be necessary to engage in, any lawsuits to recover money or
real or personal property.

                  h) Authority. The SHAREHOLDERS and Board of Directors of
PURCHASER have authorized the execution of this Agreement and the transactions
contemplated herein and it has full power and authority to execute, deliver, and
perform this Agreement.

                  i) Ability to Carry Out Obligations. The execution and
delivery of this Agreement by PURCHASER and the performance of its obligations
hereunder will not cause, constitute, conflict with or result in (i) any breach
of the provisions of any license, indenture, mortgage, charter, instrument,
certificate of incorporation, bylaw or other agreement or instrument to which it
is a party or by which it may be bound, nor will any consents or authorizations
of any party other than those hereto be required, (ii) an event that would
permit any party to any agreement or instrument to terminate it or to accelerate
the maturity of any indebtedness or other obligation, or (iii) an event that
would result in a creation or imposition of any lien, charge, or encumbrance on
any asset.

                  j) Full Disclosure. None of the representations and warranties
made by PURCHASER herein, or in any exhibit, certificate, or memorandum
furnished or to be furnished by it or on its behalf, contains or will contain
any untrue statement of a material fact, or omits any material fact, the
omission of which would be misleading.

                  k) Assets. PURCHASER has good and marketable title to all of
its property free and clear of any and all liens, claims and encumbrances.

                  l) Indemnification. PURCHASER agrees to defend and hold
SHAREHOLDERS and COMPANY and its officers and directors harmless against and in
respect to any and all claims, demands, losses, costs, expenses, obligations,
liabilities or damages, including interest, penalties, and reasonable attorneys
fees, that it shall incur or suffer, which arise out of, result from or relate
to any breach of, or failure by PURCHASER to perform any of its representations,
warranties, or covenants in this Agreement or in any exhibit or other instrument
furnished, or to be furnished, under this Agreement and from any and all claims,
demands, losses, costs, expenses, obligations, liabilities, or damages which
arise form activities subsequent to the date of the transfer of assets from
PURCHASER to COMPANY as set forth in Section 6(c).

                  m) Investment Intent. PURCHASER understands and acknowledges
that the Shares offered for sale from the SHAREHOLDERS pursuant to this
Agreement are being offered in reliance upon an exemption from registration
requirements of the Act, pursuant to the exemption commonly known as the Section
4 1 1/2 exemption and makes the following representations, agreements and
warranties with the intent that the same may be relied upon in determining the
suitability of PURCHASER as a buyer of the Shares from the SHAREHOLDERS. The
shares to be exchanged upon the Closing are offered pursuant to Section 4(2) of
the Act. Further:

                           i. The Shares are being acquired solely for the
account of PURCHASER, for investment purposes only, and not with a view to
resale or redistribution in violation of applicable state and federal securities
laws and with no present intention of distributing or reselling any part of
COMPANY's common stock acquired; and that any subsequent sale of the shares
shall be in compliance with the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder.

                           ii. PURCHASER agrees not to dispose of COMPANY's
common stock or any portion thereof unless and until counsel for COMPANY shall
have determined that the intended disposition is permissible and does not
violate the Act or any applicable Federal or state securities laws, or the rules
and regulations thereunder;

<PAGE>

                           iii. PURCHASER agrees that the certificates
evidencing the Shares acquired pursuant to this Agreement may have a legend
placed thereon stating that they have not been registered under the Act or any
state securities laws and setting forth or referring to the restrictions on
transferability and sale of COMPANY's common stock.

                           iv. PURCHASER acknowledges that COMPANY has made all
records and documentation pertaining to COMPANY's common stock available to them
and to their qualified representatives, if any, and has offered such person or
persons an opportunity to ask questions and further discuss the proposed
acquisition of COMPANY' s common stock, and any available information pertaining
thereto, with the officers and directors of COMPANY, and that all such questions
and information requested have been answered by COMPANY and its officers and
directors to PURCHASER's satisfaction;

                           v. PURCHASER has carefully evaluated their financial
resources and investment position and the risks associated with this transaction
and are able to bear the economic risks of this transaction; and they have
substantial knowledge and experience in financial, business, and investment
matters and are qualified as sophisticated investors, and are capable of
evaluating the merits and risks of this transaction; and they desire to acquire
COMPANY's common stock on the terms and conditions set forth;

                           vi. PURCHASER is able to bear the economic risk of an
investment in the Shares; and

                           vii. PURCHASER understand that an investment in the
Shares is not liquid and PURCHASER has no need for liquidity in this investment.

                  n) Receipt of Relevant Information. PURCHASER has received
from COMPANY all financial and other information concerning COMPANY and its
officers and directors, including, but not limited to, the Form 10- SB, and all
other documents and information they have requested.

                  o) Public "Shell" Corporation. PURCHASER is aware that COMPANY
has public shareholders and is a "shell" corporation without significant assets
or liabilities, and further that public companies are subject to extensive and
complex state, federal, and other regulations. Among other requirements,
PURCHASER is aware that a Form 8-K must be filed with the SEC within fifteen
days after the Closing which filing requires that audited financial statements
be filed within sixty days after the filing of the Form 8-K, and they agree that
such responsibility shall not be the responsibility of COMPANY, its officers,
directors, or employees nor the SHAREHOLDERS, but the sole responsibility of the
new officers and directors of COMPANY. PURCHASER is aware of the legal
requirements and obligations of public companies, understands that regulatory
efforts regarding public shell transactions similar to the transaction
contemplated herein has been and is currently being exerted by some state
agencies, the SEC, and the National Association of Securities Dealer, Inc.
(NASD), and are fully aware of their responsibilities, following the Closing, to
fully comply with all securities laws and regulations, and hereby agrees to do
so.

                  p) No Assurances of Warranties. PURCHASER acknowledges that
there can be no assurance regarding the tax consequences of this transaction,
nor can there be any assurance that the Internal Revenue Code or the regulations
promulgated thereunder will not be amended in such manner as to deprive them of
any tax benefit that might otherwise be received. PURCHASER is relying upon the
advice of their own tax advisors with respect to the tax aspects of this
transaction. No representations or warranties have been made by COMPANY, its
officers, directors, affiliates or agents, or by the SHAREHOLDERS as to the
benefits to be derived by PURCHASER in completing this transaction, nor have any
of them made any warranty or agreement, expressed or implied, as to the tax or
securities consequences of the transactions contemplated by this Agreement or
the tax or securities consequences of any action pursuant to or growing out of
this Agreement.

                  q) State Fees. PURCHASER acknowledges that PURCHASER shall be
fully responsible for all fees and charges incurred by the State of Delaware
relative to the outstanding capital stock of THCL.

         10) Legal Opinion. COMPANY, upon the Closing, will furnish PURCHASER an
opinion of its counsel to the affect that:

<PAGE>

                  a) COMPANY is duly organized, valid and existing in good
standing under the laws of the State of Delaware, and has authority to conduct
its business, to enter into this Agreement, and in connection therewith has
performed all acts required pursuant to the laws of Delaware in effecting this
Agreement.

                  b) COMPANY has the authority, pursuant to the corporate laws
of the State of Delaware, to issue or exchange its shares of common stock.

                  c) That such counsel has examined the representations and
warranties of COMPANY hereunder and to counsel's best knowledge, the
representations and warranties of COMPANY are true in connection therewith, and
that counsel may rely upon certificates of officers and directors of COMPANY.

                  d) That COMPANY is current in its reporting requirements with
the SEC.

                  e) That there is no pending or threatened litigation or
contingent liabilities against COMPANY.

                  f) Such other opinions as counsel may be requested to issue
and can issue based upon counsel's review of any documents or instruments in
connection therewith and associated only with the terms and transactions
contemplated by this Agreement.

         11) Investment Banking Fees. The Parties agree that Travis Morgan
Securities, Inc. (the "Investment Banker") has acted as the investment banker
for both parties in the consummation of this purchase and sale in connection
with this Agreement. The Parties also agree that the Investment Banker shall be
paid a fee of 50,000 shares of restricted common stock of THCL to be issued to
the investment Banker as soon as practicable after the Closing.

         12) Contingencies. Purchaser understands that the COMPANY may not be
able to obtain a surrender of certain pre-split shares of COMPANY totaling
approximately 25,000 relative to the COMPANY'S previous reverse-merger agreement
with Desert Sun Investments and that if said surrender and affidavit for the
release of any and all claims to the 26.22 post-split shares is not received, it
shall constitute a breach of this Agreement.

         13) Termination. Notwithstanding anything to the contrary contained in
this Agreement, this Agreement may be terminated and the transactions
contemplated hereby may be abandoned at any time prior to delivery of the
Purchase Price solely by the mutual consent of all of the parties. In the event
the transfer of PURCHASER's WEBSITE into the COMPANY does not occur by September
1, 1999 thereby commencing the exchange and distribution of BGIX shares into
THCL shares, this Agreement shall be terminated, all transfer of shares by
SHAREHOLDERS shall be rescinded and all monies paid hereunder by PURCHASER shall
be non-refundable.

         14) Waiver and Amendment. Any term, provision, covenant,
representation, warranty or condition of this Agreement may be waived, but only
by a written instrument signed by all the parties of this Agreement. The failure
or delay of any party at any time to require performance of any provision hereof
or to exercise its rights with respect to any provision hereof shall in no
manner operate as a waiver of, or affect such party's right at a later time to
enforce the same. No waiver by any party of any condition, or of the breach of
any term, provision, covenant, representation or warranty contained in this
Agreement, in any one or more instances, shall be deemed to be, or construed as,
a further or continuing waiver of any such condition or breach or waiver of any
other condition, or of the breach of any other term, provision, covenant,
representation or warranty. No modification or amendment of this Agreement shall
be valid and binding unless it be in writing and signed by all the parties
hereto.

         15) Rights and Responsibilities of the Custodian The following
provisions shall apply to the appointed Custodian, Horwitz & Beam, in the course
of performing hereunder:

                  a) Status of Custodian. The Parties acknowledge and agree
that, in acting hereunder, the Custodian has not and is not acting as counsel to
COMPANY or SHAREHOLDERS, in regard to whom the Custodian is acting solely as
Custodian hereunder.

<PAGE>

                  b) Discretion of the Custodian. In acting pursuant to this
Agreement, the Custodian shall be fully protected in every reasonable exercise
of Custodian's discretion and shall have no obligation hereunder to any other
party except as expressly set forth herein.

                  c) Fees and Expenses of the Custodian. The Custodian may
charge a reasonable fee for custodial services, which will cover all normal and
reasonable expenses of holding the shares. Such fees and expenses shall be paid
by PURCHASER.

                  d.) Liability of the Custodian. In performing any of
Custodian's duties hereunder, the Custodian shall not incur any liability to
anyone for any damages, losses, or expenses, except for willful default or
negligence and shall, accordingly, not incur any such liability with respect to
any action taken or omitted in good faith or taken or omitted in reliance upon
an instrument, including written advices provided for herein, not only as to its
due execution and the validity and effectiveness of its provisions, but also as
to the truth and accuracy of any information contained herein, which the
Custodian shall in good faith believe to be genuine, to have been signed or
presented by a proper person or persons, and to conform with the provisions of
this Agreement.

                  e.) Information and Indemnity. The Parties agree to provide to
the Custodian all information necessary to facilitate the administration of this
Agreement, and the Custodian may rely upon any representation so made. The
Parties hereby agree jointly and severally, to indemnity and hold harmless the
Custodian against any and all claims, losses, damages, liabilities, costs and
expenses, including reasonable costs of investigation aid counsel fees and
disbursements, which may be imposed upon the Custodian or incurred by the
Custodian in connection with acceptance of appointment of Custodian hereunder or
the performance of Custodian's duties hereunder, including any litigation
arising from this Agreement or involving the subject matter hereof. However,
such indemnity shall not include acts or omissions to act of the Custodian which
involve gross negligence or willful misconduct.

                  f.) Interpleader. If at any time, a dispute arises as to the
duties of the custodian or the terms hereof, the Custodian may deposit the
Shares with the Clerk of the District Court of Orange County, California, and
may interplead the other parties hereto. Upon so depositing the Shares and
filing its complaint in interpleader, the Custodian shall be completely
discharged and released from all further liability or responsibility hereunder.
The parties hereto, for themselves, their heirs, successors, assigns and legal
representatives, do hereby submit themselves to the jurisdiction of said Court
and do hereby appoint the Clerk of the said Court as their agent for services of
all process in connection with any such proceedings.

                  g) Notices: Orders of Court, Etc. The Custodian hereby is
expressly authorized and directed to disregard any and all notices or warnings
not specifically called for in or permitted by this Agreement, or by any other
person or entity not party to this Agreement, excepting only orders or process
of Court, and is hereby expressly authorized to comply with and obey any and all
orders, judgments, or decrees of any Court, and in case the Custodian obeys or
complies with any such order, judgment, or decree of any Court, shall not be
liable to any of the parties hereto or to any other person, firm, or corporation
by reason of such compliance, notwithstanding that any such order, judgment, or
decree may be subsequently reversed, modified, annulled, set aside or vacated,
or found to have been entered without jurisdiction.

         16) Notices. Any notice, request, instruction, or other document
required by the terms of this Agreement, or deemed by any of the Parties hereto
to be desirable, to be given to any other Party hereto shall be in writing and
shall be given by facsimile, personal delivery, overnight delivery, or mailed by
registered or certified mail, postage prepaid, with return receipt requested, to
the following addresses:

TO PURCHASER:

BioLogix International, Ltd.
Don Shea, President
7 Benjamin Place
Locust Valley, NY 11560
Phone: 516-759-6010
Fax: 516-759-6010

<PAGE>

BioLogix International, Ltd.
Thomas F. Lonergan, Director
9581 Cape Split Circle
Huntington Beach, CA 92646
Phone:714-962-0259
Fax: 714-593-3009

WITH A COPY TO:

Horwitz & Beam
Two Venture Plaza, Suite 350
Irvine, CA 92618
Attn: Lynne Bolduc, Esq.
Fax: 949/453-9416

TO CUSTODIAN:

Horwitz & Beam
Two Venture Plaza, Suite 350
Irvine, CA 92618
Attn: Larry Horwitz
Fax: 949/453-9416

TO COMPANY:

Innovative Tracking Solutions Corporation
23232 Peralta Drive, Suite 115
Laguna Hills, CA 92653
Attn: Dianna Cleveland, President
Fax: 949/595-4741

WITH A COPY TO:
Ken Eade 143 South. B Street
Oxnard, CA 93030
Fax: 805-483-7634

TO SHAREHOLDERS:

Dianna Cleveland
23232 Peralta Drive, Suite 115
Laguna Hills, CA 92653
Fax: 949/595-4741

Lee Namisniak
23232 Peralta Drive, Suite 115
Laguna Hills, CA 92653
Fax: 949/595-4741

<PAGE>

Lou Weiss
23232 Peralta Drive, Suite 115
Laguna Hills, CA 92653
Fax: 949/595-4741

         The persons and addresses set forth above may be changed from time to
time by a notice sent as aforesaid. If notice is given by facsimile, personal
delivery, or overnight delivery in accordance with the provisions to this
Section, said notice shall be conclusively deemed given at the time of such
delivery. If notice is given by mail in accordance with the provisions of this
Section, such notice shall be conclusively deemed given seven business days
after deposit thereof in the United States mail.

         17) Counterparts: Facsimile Signatures. This Agreement may be executed
simultaneously in one or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same
instrument. The Parties agree that facsimile signatures of this Agreement shall
be deemed a valid and binding execution of this Agreement.

         18) Jurisdiction. Any dispute, claim, or other legal proceedings in
relation to this Agreement shall be held in the County of Orange, State of
California.

         19) Governing Law. This Agreement shall be deemed to be a contract made
under the laws of the State of California and for all purposes shall be governed
by and construed in accordance with the laws of said State.

         20) Professional Fees. In the event either party hereto shall commence
legal proceedings against the other to enforce the terms hereof, or to declare
rights hereunder, as the result of a breach of any Covenant or condition of this
Agreement, the prevailing party in any such proceeding shall be entitled to
recover from the losing party its costs of suit, including reasonable attorneys'
fees, accountants' fees, and experts' fees.

         21) Miscellaneous Provisions.

                  a) This Agreement shall be binding upon and shall inure to the
benefit of the parties hereto, their beneficiaries, heirs, representatives,
assigns, and all other successors in interest.

                  b) Each of the parties shall execute any and all documents
required to be executed and perform all acts required to be performed in order
to effectuate the terms of this Agreement.

                  c) This Agreement contains all of the agreements and
understandings of the parties hereto with respect to the matters referred to
herein, and no prior agreement or understanding pertaining to any such matters
be effective for any purpose.

                  d) Each of the parties hereto has agreed to the use of the
particular language of the provisions of this Agreement, and any question of
doubtful interpretation shall not be resolved by any rule of interpretation
against the party who causes the uncertainty to exist or against the draftsman.

                  e) This Agreement may not be superseded, amended or added to
except by an agreement in writing, signed by the parties hereto, or their
respective successors-in-interest.

                  f) Any waiver of any provision of this Agreement shall not be
deemed a waiver of such provision as to any prior or subsequent breach of the
same provision or any other breach of any other provision of this Agreement.

                  g) If any provision of this Agreement is held, by a court of
competent jurisdiction, to be invalid, or enforceable, said provisions shall be
deemed deleted, and neither such provision, its severance or deletion shall
affect the validity of the remaining provisions of this Agreement, which shall,
nevertheless, continue in full force and effect.

                  h) The parties shall use their reasonable best efforts to
obtain the consent of all necessary persons and agencies to the transfer of
shares provided for in this Agreement.

<PAGE>

IN WITNESS WHEREOF, the Parties have duly executed this Agreement effective as
of the date first above written.

COMPANY                                     PURCHASER

INNOVATIVE TRACKING SOLUTIONS CORP.         BIOLOGIX INTERNATIONAL, LTD.

S/s  Dianna Cleveland                       S/s  Don Shea

By: Dianna Cleveland                        By:  Don Shea
Its: President                              Its:  President

SHAREHOLDERS
S/s  Thomas F. Lonergan
S/s  Dianna Cleveland

By:  Thomas F. Lonergan
Its:   Vice President,
Dianna  Cleveland
C.O.O., Secretary

S/s Lee Namisniak
CUSTODIAN
----------------------
Lee Namisniak

                                    HORWITZ & BEAM

S/s Lou Weiss                       S/s Larry Horwitz
Lou  Weiss                          Larry Horwitz

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}]]